PHAR vs GILD: Which Stock is Better?
Side-by-side comparison of Pharming Group NV and Gilead Sciences Inc in 2026
PHAR
Pharming Group NV
—
GILD
Gilead Sciences Inc
$135.64
Key Metrics Comparison
| Metric | PHAR | GILD | Winner |
|---|---|---|---|
| Market Cap | $723.60M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAR
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or GILD a better investment?
Comparing PHAR and GILD: Pharming Group NV has a market cap of $723.60M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and GILD?
PHAR (Pharming Group NV) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAR or GILD?
Both PHAR and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAR or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAR or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $723.60M for PHAR.
Should I buy PHAR or GILD in 2026?
Both PHAR and GILD have investment merit. PHAR trades at $N/A while GILD trades at $135.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and GILD stock?
Key differences: Market Cap ($723.60M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAR or GILD in 2026?
The choice between PHAR and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAR and GILD?
PHAR (Pharming Group NV) has a market cap of $723.60M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.